AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 74 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,611 | -33.3% | 738,906 | +6.8% | 0.01% | -18.8% |
Q2 2023 | $11,406 | +51.9% | 692,106 | -15.6% | 0.02% | +60.0% |
Q1 2023 | $7,509 | +52.9% | 819,754 | +19.5% | 0.01% | +42.9% |
Q4 2022 | $4,910 | -99.9% | 685,806 | -13.1% | 0.01% | +16.7% |
Q3 2022 | $3,952,000 | +89.6% | 788,906 | -7.6% | 0.01% | +200.0% |
Q2 2022 | $2,084,000 | -59.5% | 854,006 | +13.2% | 0.00% | -66.7% |
Q1 2022 | $5,152,000 | -24.6% | 754,306 | -10.8% | 0.01% | -33.3% |
Q4 2021 | $6,834,000 | -18.3% | 845,806 | -0.9% | 0.01% | -18.2% |
Q3 2021 | $8,362,000 | +41.8% | 853,306 | -2.6% | 0.01% | +57.1% |
Q2 2021 | $5,899,000 | -29.8% | 876,506 | -5.7% | 0.01% | -30.0% |
Q1 2021 | $8,401,000 | +20.2% | 929,306 | -11.2% | 0.01% | +25.0% |
Q4 2020 | $6,989,000 | +12.1% | 1,046,306 | -15.4% | 0.01% | +33.3% |
Q3 2020 | $6,233,000 | -42.4% | 1,236,683 | -7.6% | 0.01% | -33.3% |
Q2 2020 | $10,815,000 | +50.4% | 1,338,491 | +47.8% | 0.01% | +28.6% |
Q1 2020 | $7,192,000 | +11.5% | 905,806 | +6.1% | 0.01% | +40.0% |
Q4 2019 | $6,448,000 | +88.5% | 854,006 | +3.9% | 0.01% | +66.7% |
Q3 2019 | $3,420,000 | +47.4% | 822,006 | +2.4% | 0.00% | +50.0% |
Q2 2019 | $2,320,000 | +144.7% | 802,606 | +21.9% | 0.00% | +100.0% |
Q1 2019 | $948,000 | -40.9% | 658,336 | +5.9% | 0.00% | -50.0% |
Q4 2018 | $1,603,000 | -36.9% | 621,500 | +7.3% | 0.00% | -33.3% |
Q3 2018 | $2,542,000 | -79.0% | 579,135 | -68.4% | 0.00% | -57.1% |
Q2 2018 | $12,130,000 | +112.8% | 1,830,870 | +134.2% | 0.01% | +16.7% |
Q1 2018 | $5,699,000 | -39.3% | 781,800 | -31.7% | 0.01% | -40.0% |
Q4 2017 | $9,386,000 | +8.5% | 1,144,600 | +39.0% | 0.01% | 0.0% |
Q3 2017 | $8,649,000 | +12.3% | 823,700 | +18.0% | 0.01% | 0.0% |
Q2 2017 | $7,702,000 | +6597.4% | 698,273 | +5767.8% | 0.01% | – |
Q1 2017 | $115,000 | – | 11,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |